Springs Rejuvenation, a physician-led regenerative medicine practice, has expanded its proprietary Stem 3 Protocol to all five of its United States locations, making exosome-based hair restoration available to patients in New York City, Los Angeles, Austin, Miami, and Atlanta. The expansion eliminates the need for patients to travel abroad for this non-surgical treatment, which previously required clinics in Europe, Mexico, or Southeast Asia due to more permissive regulatory frameworks.
The Stem 3 Protocol combines three components delivered in sequence: peptide therapy, exosome hair treatment, and micro follicular unit extraction (micro FUE) performed with 0.9mm instrumentation. This smaller incision diameter, compared to conventional FUE methods using 1.0mm to 1.5mm punches, is designed to minimize scalp trauma and support faster tissue recovery. Exosomes, extracellular vesicles derived from stem cells, carry signaling proteins and growth factors that communicate with hair follicle cells. In the protocol, they are applied to prime the scalp environment before and after micro FUE, aiming to extend the active growth phase of the hair cycle and reinforce follicle density. The peptide therapy component is administered as a preparatory measure to optimize cellular conditions.
Dr. Charles Pereyra, MD, Medical Director of Springs Rejuvenation, stated: "With five active clinic locations, we have now treated patients in every major US time zone under the Stem 3 Protocol. Our 0.9mm micro FUE instrumentation paired with exosome hair treatment means patients are no longer choosing between quality and convenience - they can access this level of care in their home city." The expansion positions Springs Rejuvenation as one of the few domestic providers delivering this combination protocol at scale across multiple states.
Each of the five clinics operates under direct physician supervision, and the practice also offers stem cell exosome therapy for joint conditions, making them integrated regenerative medicine centers. Hair restoration without surgery has become an increasingly documented area within regenerative medicine, with published research examining exosome signaling in dermal papilla cells responsible for initiating and sustaining hair follicle activity. Springs Rejuvenation applies this science within a structured clinical framework, with each patient undergoing an intake assessment before the Stem 3 Protocol is initiated.
The availability of this treatment across major US cities has significant implications for the hair restoration industry, potentially shifting patient preference from surgical options to non-surgical regenerative protocols. For business leaders and technology innovators, this expansion signals growing commercial viability of exosome-based therapies and the importance of scalable clinical protocols. As regulatory landscapes evolve, more providers may follow suit, increasing competition and access. For patients, the convenience of receiving advanced care locally without international travel reduces costs and recovery time, while the physician-led model ensures quality oversight. The use of 0.9mm micro FUE also represents a technological advancement that could set new standards in minimally invasive hair restoration.
Learn more at Springs Rejuvenation.
